News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Smith & Nephew plc Announces Biomet Inc. Talks Terminated
December 18, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
As announced on 2nd November 2006, Smith & Nephew plc (LSE: SN, NYSE: SNN) has been in discussions with the Board of Biomet Inc. with a view to combining the two businesses. Smith & Nephew announces that these discussions have now been terminated.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
MORE ON THIS TOPIC
Mergers & acquisitions
Argenx deepens immuno expertise with $2.2B Forte Biosciences buy
July 27, 2026
·
2 min read
·
Tristan Manalac
Insights
Denmark’s foundation‑fueled biotech boom redraws the Nordic map
July 27, 2026
·
4 min read
·
Jennifer C. Smith-Parker
Psychedelics
Lilly’s $3.8B psychedelics bet won’t open the M&A floodgates
July 24, 2026
·
3 min read
·
Gabrielle Masson
Insights
Nordic biotech’s next act: From fragmentation to global force
July 23, 2026
·
1 min read
·
Jennifer C. Smith-Parker